TABLE 3.
Spearman correlations (ρ) between the percentages of IL-12- or TNF-α-producing myeloid DCs or monocytes and the percentages of specific-cytokine-producing or surface marker-expressing T cells for all subjects and separately within the control group and the UTI-prone group
T-cell cytokine/activation marker | % IL-12-producing myeloid DCs
|
% TNF-α-producing myeloid DCs
|
% IL-12-producing monocytes
|
% TNF-α-producing monocytes
|
||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
All subjects | Control group | UTI-prone group | All subjects | Control group | UTI-prone group | All subjects | Control group | UTI-prone group | All subjects | Control group | UTI-prone group | |
IL-2 | 0.21 | 0.30 | 0.09 | 0.19 | 0.50b | 0.07 | 0.30a | 0.21 | 0.32 | −0.08 | −0.21 | −0.12 |
IFN-γ | 0.08 | 0.14 | 0.11 | 0.41b | 0.72d | 0.20 | −0.06 | −0.23 | 0.01 | 0.20 | −0.06 | 0.40a |
IL-4 | 0.26 | 0.39 | 0.13 | 0.25 | 0.44a | 0.14 | 0.26 | 0.34 | 0.18 | 0.39b | 0.49b | 0.36a |
IL-10 | 0.49c | 0.33 | 0.42a | 0.12 | 0.17 | 0.27 | 0.49c | 0.29 | 0.33 | 0.39b | 0.45a | 0.34 |
CD69 | 0.43c | 0.22 | 0.54b | 0.10 | 0.20 | 0.11 | 0.41b | 0.18 | 0.54b | 0.09 | 0.12 | 0.04 |
CD25 | 0.46c | 0.60b | 0.20 | 0.26 | 0.27 | 0.39a | 0.46c | 0.72d | 0.11 | 0.46c | 0.47a | 0.43b |
CD54 | 0.11 | −0.07 | 0.29 | 0.17 | 0.62c | −0.12 | −0.07 | −0.34 | 0.13 | −0.10 | −0.27 | 0.06 |
CD4CD25 | 0.213 | 0.456a | −0.118 | 0.125 | 0.240 | 0.145 | 0.414c | 0.377 | 0.308 | 0.020 | −0.088 | −0.097 |
Treg celle | 0.37b | 0.60b | 0.09 | 0.23 | 0.40 | 0.23 | 0.46c | 0.43a | 0.29 | 0.35b | 0.26 | 0.43b |
Significant correlation at the 90% confidence level.
Significant correlation at the 95% confidence level.
Significant correlation at the 99% confidence level.
Significant correlation at the 99.9% confidence level.
CD4+ CD25high.